{"filing":{"accession_number":"0001171843-26-005158","cik":"0001729214","ticker":"XRTX","company_name":"XORTX Therapeutics Inc.","form":"6-K","filing_date":"2026-08-03","report_date":"2026-07-31","primary_document":"f6k_080426.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1729214/000117184326005158/f6k_080426.htm"},"events":[{"id":23479,"run_id":21230,"accession_number":"0001171843-26-005158","anchor_item_number":"EX-99.1","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Anthony Giovinazzo, who served as chairman of the board of directors, is stepping down from the board \"for personal reasons and to pursue other interests.\" This is a clear departure of a director and board chairman, a governance event material to investors assessing leadership continuity and board composition at a late-stage clinical pharmaceutical company.","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-08-03","form":"6-K","submitted_at":null,"items":[{"id":23713,"accession_number":"0001171843-26-005158","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Anthony Giovinazzo, who served as chairman of the board of directors, is stepping down from the board \"for personal reasons and to pursue other interests.\" This is a clear departure of a director and board chairman, a governance event material to investors assessing leadership continuity and board composition at a late-stage clinical pharmaceutical company.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-04T10:04:37.121253+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23713,"accession_number":"0001171843-26-005158","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Anthony Giovinazzo, who served as chairman of the board of directors, is stepping down from the board \"for personal reasons and to pursue other interests.\" This is a clear departure of a director and board chairman, a governance event material to investors assessing leadership continuity and board composition at a late-stage clinical pharmaceutical company.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-04T10:04:37.121253+00:00","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-08-03"}]}